Global Monoclonal antibodies (mAbs) Biosimilars Market Research Report 2023

Report ID: 2007000 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Erythropoietin (EPO)
        1.2.3 Human Growth Hormone (HGH)
        1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
        1.2.5 Monoclonal Antibody (mAb)
        1.2.6 Insulin
        1.2.7 Interferon (IFN)
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Anti-Cancer
        1.3.3 Anti-Inflammatory/Autoimmune
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2018-2029)
    2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Region
        2.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Region (2018-2023)
        2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Region (2024-2029)
    2.3 Monoclonal antibodies (mAbs) Biosimilars Market Dynamics
        2.3.1 Monoclonal antibodies (mAbs) Biosimilars Industry Trends
        2.3.2 Monoclonal antibodies (mAbs) Biosimilars Market Drivers
        2.3.3 Monoclonal antibodies (mAbs) Biosimilars Market Challenges
        2.3.4 Monoclonal antibodies (mAbs) Biosimilars Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue
        3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2018-2023)
        3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2018-2023)
    3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue
    3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio
        3.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2022
    3.5 Monoclonal antibodies (mAbs) Biosimilars Key Players Head office and Area Served
    3.6 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
    3.7 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Type
    4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2018-2023)
    4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2024-2029)
5 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application
    5.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Application (2018-2023)
    5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2029)
    6.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
    6.4 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2029)
    7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
    7.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2029)
    8.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2018-2023)
    8.4 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2029)
    9.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
    9.4 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size (2018-2029)
    10.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023)
    10.4 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Biocon
        11.1.1 Biocon Company Detail
        11.1.2 Biocon Business Overview
        11.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.1.5 Biocon Recent Development
    11.2 Celltrion
        11.2.1 Celltrion Company Detail
        11.2.2 Celltrion Business Overview
        11.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.2.5 Celltrion Recent Development
    11.3 Dr. Reddy's Laboratories
        11.3.1 Dr. Reddy's Laboratories Company Detail
        11.3.2 Dr. Reddy's Laboratories Business Overview
        11.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.3.5 Dr. Reddy's Laboratories Recent Development
    11.4 Hospira
        11.4.1 Hospira Company Detail
        11.4.2 Hospira Business Overview
        11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.4.5 Hospira Recent Development
    11.5 3SBio
        11.5.1 3SBio Company Detail
        11.5.2 3SBio Business Overview
        11.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.5.5 3SBio Recent Development
    11.6 Accord Healthcare
        11.6.1 Accord Healthcare Company Detail
        11.6.2 Accord Healthcare Business Overview
        11.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.6.5 Accord Healthcare Recent Development
    11.7 AET Biotech
        11.7.1 AET Biotech Company Detail
        11.7.2 AET Biotech Business Overview
        11.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.7.5 AET Biotech Recent Development
    11.8 Allergan
        11.8.1 Allergan Company Detail
        11.8.2 Allergan Business Overview
        11.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.8.5 Allergan Recent Development
    11.9 Amega Biotech
        11.9.1 Amega Biotech Company Detail
        11.9.2 Amega Biotech Business Overview
        11.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
        11.9.5 Amega Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Erythropoietin (EPO)
    Table 3. Key Players of Human Growth Hormone (HGH)
    Table 4. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF)
    Table 5. Key Players of Monoclonal Antibody (mAb)
    Table 6. Key Players of Insulin
    Table 7. Key Players of Interferon (IFN)
    Table 8. Key Players of Others
    Table 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2018-2023) & (US$ Million)
    Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2018-2023)
    Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2024-2029)
    Table 15. Monoclonal antibodies (mAbs) Biosimilars Market Trends
    Table 16. Monoclonal antibodies (mAbs) Biosimilars Market Drivers
    Table 17. Monoclonal antibodies (mAbs) Biosimilars Market Challenges
    Table 18. Monoclonal antibodies (mAbs) Biosimilars Market Restraints
    Table 19. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2018-2023) & (US$ Million)
    Table 20. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players (2018-2023)
    Table 21. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2022)
    Table 22. Ranking of Global Top Monoclonal antibodies (mAbs) Biosimilars Companies by Revenue (US$ Million) in 2022
    Table 23. Global 5 Largest Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue (CR5 and HHI) & (2018-2023)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
    Table 26. Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2018-2023) & (US$ Million)
    Table 29. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2018-2023)
    Table 30. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2024-2029)
    Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2018-2023) & (US$ Million)
    Table 33. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2018-2023)
    Table 34. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 35. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2024-2029)
    Table 36. North America Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
    Table 38. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
    Table 41. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029) & (US$ Million)
    Table 42. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2018-2023) & (US$ Million)
    Table 44. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2024-2029) & (US$ Million)
    Table 45. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029) & (US$ Million)
    Table 48. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2018-2023) & (US$ Million)
    Table 50. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2024-2029) & (US$ Million)
    Table 51. Biocon Company Detail
    Table 52. Biocon Business Overview
    Table 53. Biocon Monoclonal antibodies (mAbs) Biosimilars Product
    Table 54. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 55. Biocon Recent Development
    Table 56. Celltrion Company Detail
    Table 57. Celltrion Business Overview
    Table 58. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product
    Table 59. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 60. Celltrion Recent Development
    Table 61. Dr. Reddy's Laboratories Company Detail
    Table 62. Dr. Reddy's Laboratories Business Overview
    Table 63. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product
    Table 64. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 65. Dr. Reddy's Laboratories Recent Development
    Table 66. Hospira Company Detail
    Table 67. Hospira Business Overview
    Table 68. Hospira Monoclonal antibodies (mAbs) Biosimilars Product
    Table 69. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 70. Hospira Recent Development
    Table 71. 3SBio Company Detail
    Table 72. 3SBio Business Overview
    Table 73. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product
    Table 74. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 75. 3SBio Recent Development
    Table 76. Accord Healthcare Company Detail
    Table 77. Accord Healthcare Business Overview
    Table 78. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product
    Table 79. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 80. Accord Healthcare Recent Development
    Table 81. AET Biotech Company Detail
    Table 82. AET Biotech Business Overview
    Table 83. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product
    Table 84. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 85. AET Biotech Recent Development
    Table 86. Allergan Company Detail
    Table 87. Allergan Business Overview
    Table 88. Allergan Monoclonal antibodies (mAbs) Biosimilars Product
    Table 89. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 90. Allergan Recent Development
    Table 91. Amega Biotech Company Detail
    Table 92. Amega Biotech Business Overview
    Table 93. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product
    Table 94. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023) & (US$ Million)
    Table 95. Amega Biotech Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2022 VS 2029
    Figure 3. Erythropoietin (EPO) Features
    Figure 4. Human Growth Hormone (HGH) Features
    Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF) Features
    Figure 6. Monoclonal Antibody (mAb) Features
    Figure 7. Insulin Features
    Figure 8. Interferon (IFN) Features
    Figure 9. Others Features
    Figure 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2022 VS 2029
    Figure 12. Anti-Cancer Case Studies
    Figure 13. Anti-Inflammatory/Autoimmune Case Studies
    Figure 14. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
    Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region: 2022 VS 2029
    Figure 18. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2022
    Figure 19. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2022
    Figure 21. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2029)
    Figure 23. United States Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2029)
    Figure 27. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2018-2029)
    Figure 35. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2029)
    Figure 43. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2018-2029)
    Figure 47. Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Biocon Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 50. Celltrion Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 51. Dr. Reddy's Laboratories Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 52. Hospira Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 53. 3SBio Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 54. Accord Healthcare Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 55. AET Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 56. Allergan Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 57. Amega Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2018-2023)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Frequently Asked Questions
Monoclonal antibodies (mAbs) Biosimilars report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Monoclonal antibodies (mAbs) Biosimilars report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Monoclonal antibodies (mAbs) Biosimilars report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Macadamia

This report aims to provide a comprehensive presentation of the global market for Macadamia, with ... Read More

Machine Translation

Machine Translation market is segmented by players, region (country), by Type and by Application. ... Read More